Ibrutinib Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Data Published in The New England Journal of Medicine
- EMEA Innovative Medicine
- Ibrutinib Chronic Lymphocytic Leukemia (CLL) Data Published
Ibrutinib Chronic Lymphocytic Leukemia (CLL) Data Published
- X (Twitter)
Copy link